HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 21.034

Change

-0.01 (-0.07)%

Market Cap

USD 0.03B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
WRD:PA HSBC ETFs Public Limited Compa..

+0.55 (+1.79%)

USD 9.26B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+9.55 (+2.04%)

USD 8.86B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.53 (+1.10%)

USD 7.39B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+11.60 (+2.95%)

USD 6.76B
HHH:PA HSBC ETFs Public Limited Compa..

+0.97 (+2.06%)

USD 6.63B
WLD:PA Lyxor UCITS MSCI World D-EUR

+5.61 (+1.84%)

USD 6.20B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.30 (+1.85%)

USD 4.86B
WSRI:PA Amundi MSCI World SRI Climate ..

+1.45 (+1.62%)

USD 4.32B
500U:PA Amundi Index Solutions - Amund..

+1.65 (+1.69%)

USD 4.28B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+3.21 (+2.40%)

USD 3.71B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.44% 42% F 56% F
Dividend Return N/A 40% F 32% F
Total Return N/A 75% C 84% B
Trailing 12 Months  
Capital Gain 14.18% 49% F 65% D
Dividend Return N/A 65% D 26% F
Total Return N/A 78% C+ 84% B
Trailing 5 Years  
Capital Gain 41.18% 54% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.18% 53% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 7.15% 63% D 62% D
Dividend Return N/A 74% C 87% B+
Total Return N/A 51% F 60% D-
Risk Return Profile  
Volatility (Standard Deviation) N/A 58% F 76% C+
Risk Adjusted Return N/A 45% F 15% F
Market Capitalization 0.03B 13% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.